PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24074708-1	2013	OBJECTIVE: To evaluate the efficacy and safety of telaprevir combined with peginterferon alfa (Peg-IFNa) plus ribavirin (RBV) (collectively, TPR therapy) in patients with chronic hepatitis C (CHC) using a meta-analysis approach.	telaprevir	50-60	translocated promoter region, nuclear basket protein	Homo sapiens	141-144	
21699786-8	2011	HCV RNA levels decreased slightly among patients with HCV genotype 3 who received telaprevir and decreased rapidly among patients given PR or TPR (telaprevir had no synergistic effects with PR).	telaprevir	147-157	translocated promoter region, nuclear basket protein	Homo sapiens	142-145